Latest MedImmune Stories
GAITHERSBURG, Md., April 22, 2015 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the Board of Directors of GenVec, Inc.
OXFORD, England, April 16, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases,
SHANGHAI, March 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
-- Steady Progress in All Programs; Two Phase 2 Clinical Trials to Start in 2015 -- ROCKVILLE, Md., March 16, 2015 /PRNewswire/ --
GAITHERSBURG, Md., March 2, 2015 /PRNewswire/ -- VLP Therapeutics, LLC.
MERIDEN, Conn., Feb.
University of Maryland researchers are covering soap bubbles with biomaterials that act as a disguise, tricking the body’s cells into mistaking the capsule for a bacterium, a cancer cell or
NORWALK, Conn., Jan.
NEW YORK, Dec.
Clinical Development, Manufacturing Expertise, and Scale Critical to Success WHITEHOUSE STATION, N.J. and AMES, IA, Nov.
- A person in a secondary role, specifically the second most important character (after the protagonist).